This Discussion Paper provides a brief status of the pharmaceutical industry in India and its key features. It gives a description of the major regulatory bodies monitoring the Indian pharmaceutical sector and undertakes a review of the prevailing mechanisms for drug regulation and some predominant policy measures and acts. It also provides a comprehensive account of the status and key challenges.